Your browser doesn't support javascript.
loading
A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial.
Drooger, Jan C; van Tinteren, Harm; de Groot, Steffen M; Ten Tije, Albert J; de Graaf, Hiltje; Portielje, Johanneke E A; Jager, Agnes; Honkoop, Aafke; Linn, Sabine C; Kroep, Judith R; Erdkamp, Frans L G; Hamberg, Paul; Imholz, Alex L T; van Rossum-Schornagel, Quirine C; Heijns, Joan B; van Leeuwen-Stok, A Elise; Sleijfer, Stefan.
Afiliação
  • Drooger JC; Department of Medical Oncology, Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands. j.drooger@ikazia.nl.
  • van Tinteren H; Department of Medical Oncology, Ikazia Hospital, Rotterdam, the Netherlands. j.drooger@ikazia.nl.
  • de Groot SM; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Ten Tije AJ; Comprehensive Cancer Center of the Netherlands, Amsterdam, the Netherlands.
  • de Graaf H; Department of Medical Oncology, Amphia Hospital, Breda, the Netherlands.
  • Portielje JE; Department of Medical Oncology, Leeuwarden Medical Center, Leeuwarden, the Netherlands.
  • Jager A; Department of Medical Oncology, Haga Hospital, the Hague, the Netherlands.
  • Honkoop A; Department of Medical Oncology, Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands.
  • Linn SC; Department of Medical Oncology, Isala Clinic, Zwolle, the Netherlands.
  • Kroep JR; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Erdkamp FL; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Hamberg P; Department of Medical Oncology, Orbis Medical Center, Sittard, the Netherlands.
  • Imholz AL; Department of Medical Oncology, Sint Franciscus Gasthuis, Rotterdam, the Netherlands.
  • van Rossum-Schornagel QC; Department of Medical Oncology, Deventer Hospital, Deventer, the Netherlands.
  • Heijns JB; Department of Medical, Oncology, Vlietland Hospital, Schiedam, the Netherlands.
  • van Leeuwen-Stok AE; Department of Medical Oncology, Amphia Hospital, Breda, the Netherlands.
  • Sleijfer S; Dutch Breast Cancer Research Group, Amsterdam, the Netherlands.
Cancer ; 122(19): 2961-70, 2016 Oct.
Article em En | MEDLINE | ID: mdl-27315546
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Neoplasias Hepáticas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Neoplasias Hepáticas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2016 Tipo de documento: Article